Ozempic vs Victoza: How the Newer Semaglutide Compares

If you've been researching GLP-1 medications, you've probably come across both Ozempic and Victoza. They're both FDA-approved for type 2 diabetes, both injectable GLP-1 receptor agonists, and both have shown real promise for weight loss. But here's the thing: Ozempic, the newer medication, has largely overshadowed Victoza in recent years—and for good reason. Let's walk through what makes these medications different, how they compare in real-world use, and what that means for your health journey.

Understanding the Basics: What Are These Medications?

Both Ozempic and Victoza belong to a class of medications called GLP-1 receptor agonists. That's a mouthful, but it simply means they mimic a natural hormone in your body called GLP-1 (glucagon-like peptide-1) that helps regulate blood sugar and appetite.

Victoza contains liraglutide and was approved by the FDA back in 2010. It was one of the earlier GLP-1 medications and represented a real breakthrough at the time. Ozempic, which contains semaglutide, came along in 2017 and is essentially a next-generation version of the same concept—but with some significant improvements.

The key difference? Semaglutide (Ozempic) stays in your body much longer than liraglutide (Victoza), which changes everything about how you use it and what results you can expect.

Dosing: Once Daily vs Once Weekly

This is where the difference becomes immediately practical in your everyday life.

Victoza requires a daily injection. You'll use it once every day, typically at the same time, starting at 0.6 mg and potentially increasing to 1.2 mg or 1.8 mg depending on how your body responds and what your doctor recommends.

Ozempic, on the other hand, only requires a once-weekly injection. You start at 0.25 mg for the first month (mostly to help your body adjust), then typically increase to 0.5 mg, and potentially up to 1 mg or even 2 mg if needed for blood sugar control or weight loss.

For many people, that weekly injection schedule is simply easier to remember and stick with long-term. There's something liberating about not having to think about your medication every single day. That said, some people actually prefer the daily routine—it feels more consistent and controllable to them.

Weight Loss Results: The Numbers Tell a Story

Both medications can lead to meaningful weight loss, but the clinical trials show that semaglutide tends to produce more significant results.

In studies, people taking Victoza lost an average of 5-6 pounds over 26 weeks when using it for diabetes management. When liraglutide was studied specifically for weight loss (under the brand name Saxenda, which is a higher dose), people lost about 5-10% of their body weight over a year.

Ozempic showed notably better results. In the SUSTAIN clinical trials, people taking 1 mg of semaglutide weekly lost an average of 12-14 pounds over 6 months, and some participants continued losing weight beyond that point. When higher-dose semaglutide was studied specifically for weight loss (as Wegovy), average weight loss reached 15-20% of body weight over 68 weeks.

These are averages, of course. Some people respond more dramatically, others less so. But the pattern is clear: semaglutide generally leads to more weight loss than liraglutide at comparable timeframes.

How They Work in Your Body

Both medications work through the same basic mechanisms, but semaglutide's longer half-life means it maintains more consistent levels in your bloodstream.

They both help by slowing down how quickly your stomach empties after eating, which keeps you feeling fuller longer. They also work in your brain to reduce appetite and food cravings. And they help your pancreas release the right amount of insulin when your blood sugar rises after meals.

The difference is that liraglutide (Victoza) has a half-life of about 13 hours, so it's mostly out of your system within a day or two. Semaglutide (Ozempic) has a half-life of about 7 days, which is why it only needs to be injected weekly and why it maintains steadier levels that may translate to better appetite control throughout the week.

Side Effects: What to Expect

Here's the honest truth: both medications can cause similar side effects, and the most common ones are gastrointestinal.

You might experience nausea, especially when starting or increasing your dose. Some people also deal with vomiting, diarrhea, constipation, or stomach discomfort. These side effects are usually worst in the first few weeks as your body adjusts.

Interestingly, because Ozempic is dosed weekly rather than daily, some people find the side effects more manageable—your body has more time to adjust between doses. Others find that the daily dosing of Victoza feels gentler because there's less medication hitting your system at once. It really varies from person to person.

Both medications carry the same black box warning about thyroid C-cell tumors observed in rodent studies, so they shouldn't be used if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Cost and Access Considerations

Without insurance, both medications are expensive—often $900-1000 per month or more at retail prices. Insurance coverage varies widely, though Ozempic tends to be better covered now because it's become more widely prescribed and recognized.

Victoza has been around longer, so you'd think it might be cheaper, but that's not always the case. Generic versions aren't yet available for either medication.

This is where compounded semaglutide has become a game-changer for many people. It provides access to the same active ingredient at a fraction of the cost, making this newer, more effective medication accessible to people who couldn't otherwise afford it.

Which One Is Right for You?

In clinical practice, most doctors now start with semaglutide (Ozempic or compounded semaglutide) rather than liraglutide (Victoza) when beginning GLP-1 therapy. The once-weekly dosing, stronger weight loss results, and comparable safety profile make it the preferred choice for most patients.

That said, Victoza still has its place. Some people genuinely prefer daily injections, and some insurance plans cover Victoza but not Ozempic. If you're already on Victoza and it's working well for you, there may not be a compelling reason to switch.

The best choice depends on your individual health profile, your lifestyle preferences, your insurance coverage, and your specific goals around weight loss and blood sugar management.

For Women

Women tend to experience GLP-1 side effects slightly more intensely than men, particularly nausea. Starting with the lowest dose and increasing slowly is especially important. Also worth noting: if you're of childbearing age, both medications should be stopped at least 2 months before trying to conceive, as their effects on pregnancy aren't fully understood.

For Men

Men often see faster initial weight loss on GLP-1 medications, partly because they typically start at higher body weights and have higher baseline metabolic rates. However, men are also statistically less likely to report side effects to their doctors—don't tough it out if you're experiencing persistent nausea or other concerning symptoms. Your care team can adjust your dose or timing to help.

From the Ozari Care Team

If you're switching from Victoza to semaglutide, expect a transition period. Even though they're similar medications, your body will need time to adjust to the new dosing schedule and the longer-acting formulation. We typically recommend starting at the lowest semaglutide dose regardless of what dose you were on with Victoza, then titrating up based on your response and tolerance.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team — licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 24, 2026